Sowa M., Kolenda R., Baumgart D.C., Pratschke J., Papp M., Tornai T., Suchanski J., Bogdanos D.P., Mytilinaiou M.G., Hammermann J., Laass M.W., Conrad K., Schramm C., Franke A., Roggenbuck D., Schierack P. (2018)
Introduction: Zymogen granule glycoprotein 2 (GP2) was demonstrated as first autoimmune mucosal target in primary sclerosing cholangitis (PSC) associated with disease severity. Autoantibodies to four GP2 isoforms (aGP21−4) ...